Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

Yuki Kojima · SciRah

Researcher profile · Semantic Scholar

Yuki Kojima

Share profile

Yuki Kojima — researcher profile on SciRah

h-index: 17
Works: 105
Citations: 802

Most-cited papers

Difference in SARS-CoV-2 Antibody Status Between Patients With Cancer and Health Care Workers During the COVID-19 Pandemic in Japan.
S. Yazaki, T. Yoshida, Yuki Kojima, S. Yagishita +16 more
2021JAMA Oncology54 citations Open access
Semantic Scholar
Highly sensitive fusion detection using plasma cell‐free RNA in non‐small‐cell lung cancers
Nobuhiko Hasegawa, S. Kohsaka, K. Kurokawa, Y. Shinno +15 more
2021Cancer Science51 citations Open access
Semantic Scholar
Efficacy of anti-CD47 antibody-mediated phagocytosis with macrophages against primary effusion lymphoma.
H. Goto, Yuki Kojima, K. Matsuda, R. Kariya +5 more
2014European Journal of Cancer47 citations
Semantic Scholar
Acute thrombotic thrombocytopenic purpura after pneumococcal vaccination.
Yuki Kojima, H. Ohashi, Tomonobu Nakamura, Hiroyuki Nakamura +4 more
2014Blood Coagulation and Fibrinolysis38 citations
Semantic Scholar
Impact of ALK Inhibitors in Patients With ALK-Rearranged Nonlung Solid Tumors
Takeyasu Yuki, H. Okuma, Yuki Kojima, T. Nishikawa +12 more
2021JCO Precision Oncology35 citations Open access
Semantic Scholar
Classification of AIDS-related lymphoma cases between 1987 and 2012 in Japan based on the WHO classification of lymphomas, fourth edition
Y. Ota, T. Hishima, M. Mochizuki, Y. Kodama +20 more
2014Cancer Medicine32 citations Open access
Semantic Scholar
Anti-tumor immunity enhancement by photodynamic therapy with talaporfin sodium and anti-programmed death 1 antibody
Makiko Sasaki, Mamoru Tanaka, Yuki Kojima, H. Nishie +3 more
2023Molecular Therapy: Oncolytics30 citations Open access
Semantic Scholar
Clinical activity and exploratory resistance mechanism of milademetan, an MDM2 inhibitor, in intimal sarcoma with MDM2 amplification: an open-label phase 1b/2 study.
T. Koyama, T. Shimizu, Yuki Kojima, K. Sudo +14 more
2023Cancer Discovery30 citations
Semantic Scholar
The photosensitizer verteporfin has light-independent anti-leukemic activity for Ph-positive acute lymphoblastic leukemia and synergistically works with dasatinib
Takanobu Morishita, F. Hayakawa, K. Sugimoto, M. Iwase +6 more
2016OncoTarget22 citations Open access
Semantic Scholar
Emetine elicits apoptosis of intractable B-cell lymphoma cells with MYC rearrangement through inhibition of glycolytic metabolism
T. Aoki, K. Shimada, A. Sakamoto, K. Sugimoto +11 more
2016OncoTarget22 citations Open access
Semantic Scholar
Establishment of a CD4-positive cell line from an AIDS-related primary effusion lymphoma
H. Goto, Yuki Kojima, H. Nagai, S. Okada
2013International journal of hematology22 citations
Semantic Scholar
BRCA1 promoter methylation in breast cancer patients is associated with response to olaparib/eribulin combination therapy
A. Kawachi, S. Yamashita, E. Okochi‐Takada, A. Hirakawa +8 more
2020Breast Cancer Research and Treatment20 citations
Semantic Scholar
B Cell Linker Protein (BLNK) Is a Selective Target of Repression by PAX5-PML Protein in the Differentiation Block That Leads to the Development of Acute Lymphoblastic Leukemia*
Naoto Imoto, F. Hayakawa, S. Kurahashi, Takanobu Morishita +6 more
2015Journal of Biological Chemistry19 citations Open access
Semantic Scholar
Integrative prognostic analysis of tumor–infiltrating lymphocytes, CD8, CD20, programmed cell death-ligand 1, and tertiary lymphoid structures in patients with early-stage triple-negative breast cancer who did not receive adjuvant chemotherapy
S. Yazaki, Tatsusnori Shimoi, Masayuki Yoshida, Hitomi Sumiyoshi-Okuma +16 more
2022Breast Cancer Research and Treatment18 citations Open access
Semantic Scholar
High expression of folate receptor alpha is associated with poor prognosis in patients with cervical cancer
S. Yazaki, Yuki Kojima, H. Yoshida, S. Takamizawa +14 more
2022Journal of Gynecologic Oncology18 citations Open access
Semantic Scholar
YM155 induces apoptosis through proteasome‐dependent degradation of MCL‐1 in primary effusion lymphoma
Yuki Kojima, F. Hayakawa, Takanobu Morishita, K. Sugimoto +8 more
2017Pharmacological Research18 citations
Semantic Scholar
Comparison of dose intensity of vincristine, d-actinomycin, and cyclophosphamide chemotherapy for child and adult rhabdomyosarcoma: a retrospective analysis
Yuki Kojima, K. Hashimoto, M. Ando, K. Yonemori +8 more
2012Cancer Chemotherapy and Pharmacology18 citations
Semantic Scholar
Clinical outcomes of adult and childhood rhabdomyosarcoma treated with vincristine, d-actinomycin, and cyclophosphamide chemotherapy
Yuki Kojima, K. Hashimoto, M. Ando, K. Yonemori +9 more
2012Journal of Cancer Research and Clinical Oncology17 citations Open access
Semantic Scholar
Folate receptor alpha is widely expressed and a potential therapeutic target in uterine and ovarian carcinosarcoma.
A. Saito, T. Nishikawa, H. Yoshida, C. Mizoguchi +7 more
2023Gynecologic Oncology16 citations
Semantic Scholar
Chromosomal translocation-mediated evasion from miRNA induces strong MEF2D fusion protein expression, causing inhibition of PAX5 transcriptional activity
Daiki Hirano, F. Hayakawa, T. Yasuda, Naoyuki Tange +8 more
2018Oncogene16 citations Open access
Semantic Scholar
Changes in HER3 expression profiles between primary and recurrent gynecological cancers
Yuki Kojima, K. Sudo, H. Yoshida, S. Yazaki +17 more
2023Cancer Cell International14 citations Open access
Semantic Scholar
Lymphocyte-to-monocyte ratio as a prognostic and potential tumor microenvironment indicator in advanced soft tissue sarcoma treated with first-line doxorubicin therapy
Sho Watanabe, T. Shimoi, T. Nishikawa, A. Kawachi +15 more
2023Scientific Reports14 citations Open access
Semantic Scholar
Low HER2 expression is a predictor of poor prognosis in stage I triple-negative breast cancer
Tomomi Sanomachi, H. Okuma, R. Kitadai, A. Kawachi +18 more
2023Frontiers in Oncology14 citations Open access
Semantic Scholar
Neoadjuvant chemotherapy promotes the expression of HER3 in patients with ovarian cancer
T. Mizuno, Yuki Kojima, K. Yonemori, H. Yoshida +15 more
2020Oncology Letters13 citations Open access
Semantic Scholar
ZNF384‐fusion proteins have high affinity for the transcriptional coactivator EP300 and aberrant transcriptional activities
Hideyuki Yamamoto, F. Hayakawa, T. Yasuda, Koya Odaira +8 more
2019FEBS Letters13 citations Open access
Semantic Scholar
Poor Treatment Outcomes with Second-Line Chemotherapy in Advanced Synovial Sarcoma
Yuki Kojima, Tatsusnori Shimoi, T. Seo, S. Yazaki +15 more
2022Oncology12 citations
Semantic Scholar
A Support System for Adolescent and Young Adult Patients with Cancer at a Comprehensive Cancer Center
H. Ishiki, Takatoshi Hirayama, Saki Horiguchi, Ikumi Iida +18 more
2021JMA Journal12 citations Open access
Semantic Scholar
Clinical management and outcomes associated with etoposide, doxorubicin, and cisplatin plus mitotane treatment in metastatic adrenocortical carcinoma: a single institute experience
Masaki Uchihara, M. Tanioka, Yuki Kojima, T. Nishikawa +5 more
2021International Journal of Clinical Oncology12 citations
Semantic Scholar
Neutrophil-to-lymphocyte ratio as a prognostic factor for patients with metastatic or recurrent breast cancer treated using capecitabine: a retrospective study
S. Takamizawa, T. Shimoi, Natsuko Satomi-Tsushita, S. Yazaki +8 more
2022BMC Cancer11 citations Open access
Semantic Scholar
Sterilized talc pleurodesis for malignant pleural effusions: a Phase II study for investigational new drug application in Japan
H. Saka, Masahide Oki, C. Kitagawa, Y. Kogure +8 more
2018Japanese Journal of Clinical Oncology10 citations
Semantic Scholar
Impact of adjuvant chemotherapy and radiotherapy on tumour-infiltrating lymphocytes and PD-L1 expression in metastatic breast cancer
S. Yazaki, R. Salgado, Tatsusnori Shimoi, Masayuki Yoshida +12 more
2022British Journal of Cancer9 citations Open access
Semantic Scholar
Is adjuvant chemotherapy necessary in older patients with breast cancer?
M. Morita, A. Shimomura, E. Tokuda, Y. Horimoto +7 more
2022Breast Cancer9 citations Open access
Semantic Scholar
PAX5 tyrosine phosphorylation by SYK co-operatively functions with its serine phosphorylation to cancel the PAX5-dependent repression of BLIMP1: A mechanism for antigen-triggered plasma cell differentiation.
Y. Inagaki, F. Hayakawa, Daiki Hirano, Yuki Kojima +4 more
2016Biochemical and Biophysical Research Communications - BBRC9 citations
Semantic Scholar
A multi-institutional study of clinicopathological features and molecular epidemiology of epidermal growth factor receptor mutations in lung cancer patients living with human immunodeficiency virus infection
Y. Okuma, J. Tanuma, Hiroshi Kamiryo, Yuki Kojima +7 more
2015Journal of Cancer Research and Clinical Oncology9 citations Open access
Semantic Scholar
Clinical outcomes of AIDS-related Burkitt lymphoma: a multi-institution retrospective survey in Japan.
Yuki Kojima, S. Hagiwara, T. Uehira, A. Ajisawa +4 more
2014Japanese Journal of Clinical Oncology8 citations
Semantic Scholar
Clinical characteristics of primary cutaneous and subcutaneous Ewing sarcoma.
Hisaki Aiba, Yuki Kojima, T. Shimoi, K. Sudo +10 more
2023Japanese Journal of Clinical Oncology7 citations
Semantic Scholar
Development of a Detection System for ESR1 Mutations in Circulating Tumour DNA Using PNA-LNA-Mediated PCR Clamping
Yuki Kojima, E. Noguchi, Tomomi Yoshino, S. Yagishita +13 more
2023Diagnostics7 citations Open access
Semantic Scholar
High mesothelin expression is correlated with non-squamous cell histology and poor survival in cervical cancer: a retrospective study
S. Takamizawa, S. Yazaki, Yuki Kojima, H. Yoshida +12 more
2022BMC Cancer7 citations Open access
Semantic Scholar
A multicenter investigator-initiated Phase 2 trial of E7090 in patients with advanced or recurrent solid tumor with fibroblast growth factor receptor (FGFR) gene alteration: FORTUNE trial
Y. Chiba, K. Sudo, Yuki Kojima, H. Okuma +13 more
2022BMC Cancer7 citations Open access
Semantic Scholar
Development of an optimal protocol for molecular profiling of tumor cells in pleural effusions at single‐cell level
I. Nakamura, Masachika Ikegami, Nobuhiko Hasegawa, Takuo Hayashi +11 more
2021Cancer Science7 citations Open access
Semantic Scholar
HER3 protein expression as a risk factor for post-operative recurrence in patients with early-stage adenocarcinoma and adenosquamous carcinoma of the cervix
T. Mizuno, Yuki Kojima, K. Yonemori, H. Yoshida +15 more
2020Oncology Letters7 citations Open access
Semantic Scholar
Prognosis of mature T cell lymphoma is poorer than that of diffuse large B cell lymphoma in IPI low-risk group, but not in intermediate- and high-risk groups
R. Kihara, Tomoyuki Watanabe, T. Yano, N. Uike +12 more
2012International journal of hematology6 citations
Semantic Scholar
Feasibility of an Electronic Patient-Reported Outcome Tool for Screening Distress and Supportive Care Needs of Adolescents and Young Adults with Cancer
Takatoshi Hirayama, H. Ishiki, Yuko Yanai, Saki Horiguchi +9 more
2023Journal of Adolescent and Young Adult Oncology4 citations Open access
Semantic Scholar
Diagnostic value of tumor markers in identifying favorable or unfavorable subsets in patients with cancer of unknown primary: a retrospective study
S. Takamizawa, T. Shimoi, Masayuki Yoshida, M. Tokura +11 more
2022BMC Cancer4 citations Open access
Semantic Scholar
Clinical Utility of Circulating Tumor DNA in Advanced Rare Cancers
H. Okuma, K. Yonemori, Yuki Kojima, M. Tanioka +15 more
2021Frontiers in Oncology4 citations Open access
Semantic Scholar
Clinical Impact of Aprepitant in Patients Receiving High-Dose Chemotherapy prior to Autologous Peripheral Blood Stem Cell Transplantation: A Cost-Effectiveness Analysis
Ayumi Nakamura, Yuki Kojima, K. Miyazawa, S. Matsumoto +2 more
2017Oncology4 citations
Semantic Scholar
End-of-life care for HIV-infected patients with malignancies: A questionnaire-based survey
Yuki Kojima, Nami Iwasaki, Y. Yanaga, J. Tanuma +7 more
2016Palliative Medicine4 citations
Semantic Scholar
Discordance in PD-L1 expression using 22C3 and SP142 assays between primary and metastatic triple-negative breast cancer
J. Miyakoshi, S. Yazaki, T. Shimoi, M. Onishi +15 more
2023Virchows Archiv3 citations
Semantic Scholar
Predictive value of peripheral blood markers in soft tissue sarcoma patients treated with eribulin.
Shin Ishihara, Koichi Ogura, A. Maeshima, T. Shimoi +9 more
2023Japanese Journal of Clinical Oncology3 citations
Semantic Scholar
Targeted-sequencing in rare cancers and the impact on patient treatment.
H. Okuma, T. Kubo, H. Ichikawa, T. Kohno +10 more
2019Journal of Clinical Oncology3 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

K. Yonemori×27
Invite
K. Yonemori — researcher profile on SciRah
K. Sudo×21
Invite
K. Sudo — researcher profile on SciRah
T. Nishikawa×17
Invite
T. Nishikawa — researcher profile on SciRah
E. Noguchi×17
Invite
E. Noguchi — researcher profile on SciRah

×15

Invite

S. Yazaki — researcher profile on SciRah

Invite

H. Okuma — researcher profile on SciRah

Invite

T. Shimoi — researcher profile on SciRah

Y. Fujiwara×14

Invite

Y. Fujiwara — researcher profile on SciRah

Invite

M. Tanioka — researcher profile on SciRah

Invite

H. Nagai — researcher profile on SciRah

Invite

K. Tamura — researcher profile on SciRah

Invite

S. Okada — researcher profile on SciRah